We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
I am a clinical cardiologist specializing in the comprehensive management of co-existing cardiovascular disease and cancer as well as the cardio-toxic side effects of chemotherapy treatment. Through close collaboration with the cancer treatment team, my goal is to ensure the best outcomes for patients with cancer who are at risk for or who have concurrent cardiovascular disease.
I work closely with the oncologists to monitor patient’s cardiovascular health during treatment and provide long-term follow-up cardiac care for cancer survivors. I also provide cardiac evaluation for patients with cancer who are scheduled to undergo major surgery or to receive potentially cardio-toxic cancer treatment.
Read more
My clinical research focuses on providing earlier detection of cardio-toxic side effects of cancer treatment through the use of specialized cardiac imaging tests. I am dedicated to finding new ways to prevent, diagnose, and treat cardiac disease as a complication of cancer treatment.
My Role at MSK
A cardiologist is a doctor with special training in the cardiovascular system (heart and blood vessels).
Areas of Expertise
My Specialties
Clinical cardiology
Echocardiography
Nuclear Cardiology
Education & Honors
Education
MD, Harvard Medical School
MS, Cornell University
Residencies
Hospital of the University of Pennsylvania
Fellowships
Mount Sinai Medical Center (New York)
Board Certifications
Cardiovascular Disease
Echocardiography
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
Aetna
In Network Coverage Type HMO, EPO PPO, POS, Transplant
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Visit PubMed for a full listing of Dr. Yu’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
We strive to keep reviews trustworthy, honest and fair.
Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Anthony F. Yu discloses the following relationships and financial interests:
Genentech Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
